Prevention, treatment and cure of HIV infection

RJ Landovitz, H Scott, SG Deeks - Nature Reviews Microbiology, 2023 - nature.com
The development of antiretroviral therapy for the prevention and treatment of HIV infection
has been marked by a series of remarkable successes. However, the efforts to develop a …

Mass spectrometry-based structural virology

TP Wörner, TM Shamorkina, J Snijder… - Analytical …, 2020 - ACS Publications
Here we review recent developments in mass spectrometry that have enabled its growing
contribution to the field of structural virology. Evidently, there is a strong renewed general …

Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site

TG Caniels, M Medina-Ramìrez, S Zhang… - Science …, 2024 - science.org
Eliciting potent and broadly neutralizing antibodies (bnAbs) is a major goal in HIV-1 vaccine
development. Here, we describe how germline-targeting immunogen BG505 SOSIP …

Allelic polymorphism controls autoreactivity and vaccine elicitation of human broadly neutralizing antibodies against influenza virus

M Sangesland, AT de la Peña, S Boyoglu-Barnum… - Immunity, 2022 - cell.com
Human broadly neutralizing antibodies (bnAbs) targeting the hemagglutinin stalk of group 1
influenza A viruses (IAVs) are biased for IGHV1-69 alleles that use phenylalanine (F54) but …

Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimers as HIV-1 vaccine …

YN Zhang, J Paynter, A Antanasijevic, JD Allen… - Nature …, 2023 - nature.com
Uncleaved prefusion-optimized (UFO) design can stabilize diverse HIV-1 envelope
glycoproteins (Envs). Single-component, self-assembling protein nanoparticles (1c-SApNP) …

Broad and potent neutralizing antibodies recognize the silent face of the HIV envelope

T Schoofs, CO Barnes, N Suh-Toma, J Golijanin… - Immunity, 2019 - cell.com
Broadly neutralizing antibodies (bNAbs) against HIV-1 envelope (Env) inform vaccine
design and are potential therapeutic agents. We identified SF12 and related bNAbs with up …

Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins

HV Dang, RW Cross, V Borisevich… - Nature Structural & …, 2021 - nature.com
Abstract Hendra virus (HeV) and Nipah virus (NiV) are henipaviruses (HNVs) causing
respiratory illness and severe encephalitis in humans, with fatality rates of 50–100%. There …

Rapid and focused maturation of a VRC01-class HIV broadly neutralizing antibody lineage involves both binding and accommodation of the N276-glycan

J Umotoy, BS Bagaya, C Joyce, T Schiffner, S Menis… - Immunity, 2019 - cell.com
Summary The VH1-2 restricted VRC01-class of antibodies targeting the HIV envelope CD4
binding site are a major focus of HIV vaccine strategies. However, a detailed analysis of …

Simply extending the mass range in electron transfer higher energy collisional dissociation increases confidence in N-glycopeptide identification

T Čaval, J Zhu, AJR Heck - Analytical chemistry, 2019 - ACS Publications
Glycopeptide-centric mass spectrometry has become a popular approach for studying
protein glycosylation. However, current approaches still utilize fragmentation schemes and …

Microsecond dynamics control the HIV-1 envelope conformation

AL Bennett, R Edwards, I Kosheleva, C Saunders… - Science …, 2024 - science.org
The HIV-1 Envelope (Env) glycoprotein facilitates host cell fusion through a complex series
of receptor-induced structural changes. Although remarkable progress has been made in …